3EO Health is collaborating with U.S. manufacturers to produce and assemble its molecular COVID testing platform.
BOSTON—3EO Health, a “Point of Life” diagnostics company, is taking steps to solidify a U.S.-based supply chain by collaborating with key domestic manufacturing partners on production of its lower-cost molecular COVID test kit, the company said in a release.
3EO Health focuses on development of high-performing, low-cost molecular diagnostics for point-of-care and community settings. The company recently established partnerships with two U.S.-based manufacturers—Plastikon Industries and Asteelflash—to supply its consumables and instrumentation. Its first product is a molecular COVID testing platform that is said to cost up to 70 percent less than existing technologies, making it more accessible to a broader swath of the U.S. population.
Plastikon is a plastics contract manufacturer for the healthcare and medical device (including diagnostics), automotive, and electronics industries. With capabilities in injection molding and thermoforming, the company supports healthcare with numerous medical-grade plastic parts, instruments, and assemblies. Its products include labware, single-use systems, sterilizable systems, drug delivery systems, thermoformed packaging, and dental, surgical, and orthopedic instruments.
Asteelflash is a contract manufacturer that specializes in electronics manufacturing services (EMS) and supply chain management. The company offers printed circuit board assembly (PCBA), system assembly, testing, and fulfillment.
3EO Heath’s “key,” the consumable portion of its testing platform, is manufactured by Plastikon Industries at its Hayward, California facility. The “cube,” the instrument portion of the testing platform, is manufactured by Asteelflash at its Fremont, California location.
“We are delighted to be supply partners for 3EO Health’s diagnostic product,” said Asteelflash General Manager Roberto Tongo, in the release. “Asteelflash/USI fully embraces 3EO’s principles, advocating for a future built on shared, stringent, commitment to our medical manufacturing ideals and creating local jobs by producing essential components that play crucial roles in our daily lives.”